Moneycontrol
SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Divis Laboratories

Divis Laboratories

BSE: 532488|NSE: DIVISLAB|ISIN: INE361B01024|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Jun 23, 16:00
638.45
-1.95 (-0.3%)
VOLUME 56,666
LIVE
NSE
Jun 23, 16:01
638.60
-1.85 (-0.29%)
VOLUME 503,545
News on Divis Laboratories
Select Year: 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
See upside in Divis Laboratories, says Shahina Mukadam 

3.50 pm | 14 Jun 2017 |  Source: CNBC-TV18

Shahina Mukadam, Independent Market Expert is of the view that one may hold Divis Laboratories....

Hold Divi’s Laboratories; target of Rs 625: ICICI Direct

4.51 pm | 31 May 2017 |  Source: Moneycontrol.com

ICICI Direct recommended hold rating on Divi’s Laboratories with a target price of Rs 625 in its research report dated May 29, 2017....

Divis Laboratories' board meeting on May 26, 2017

12.34 pm | 15 May 2017 |  Source: Moneycontrol.com

Notice is hereby given that a meeting of Board of Directors of the Company is scheduled to be held on Friday, the 26th day of May 2017, inter-alia, to...

Hold Divi's Laboratories; target of Rs 690: Axis Direct

1.20 pm | 11 Apr 2017 |  Source: Moneycontrol.com

Axis Direct recommended hold rating on Divi's Laboratories with a target price of Rs 690 in its research report dated April 10, 2017....

Top trading ideas by SP Tulsian

9.14 am | 01 Mar 2017 |  Source: CNBC-TV18

In an interview to CNBC-TV18 SP Tulsian, sptulsian.com shared his reading and outlook on the market and also gave recommendations on various stocks....

Hold Divi's Laboratories; target of Rs 740: Axis Direct

3.40 pm | 20 Feb 2017 |  Source: Moneycontrol.com

Axis Direct recommended hold rating on Divi's Laboratories with a target price of Rs 740 in its research report dated February 10, 2017....

Buy Divi’s Laboratories; target of Rs 925: ICICI Direct

4.53 pm | 09 Feb 2017 |  Source: Moneycontrol.com

ICICI Direct is bullish on Divi’s Laboratories has recommended buy rating on the stock with a target price of Rs 925 in its research report dated Fe...

Buy Divi’s Laboratories; target of Rs 925: ICICI Direct

3.37 pm | 07 Feb 2017 |  Source: Moneycontrol.com

ICICI Direct is bullish on Divi’s Laboratories has recommended buy rating on the stock with a target price of Rs 925 in its research report dated Fe...

Divis Labs Q3 net profit up 9% at Rs 268.32 crore

4.16 pm | 04 Feb 2017 |  Source: PTI

Drug firm Divis Laboratories today reported a 8.73 per cent rise in standalone net profit to Rs 268.32 crore for the quarter ended December 31, 2016...

Divis Q3 net likely up 11%, margins may be at 37%

4.51 pm | 27 Jan 2017 |  Source: Moneycontrol.com

Street will be squarely focused on commentary on 5 observations co received on its unit 2 by USFDA, inspected from Nov 29 to December 6. Analysts expe...

1 2 3 4
Quick Links for Divis Laboratories
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.